Erschienen in:
30.08.2018 | ASO Author Reflections
ASO Author Reflections: Hypoxia-Induced PLOD2 Is a Key Regulator in Epithelial–Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer
verfasst von:
Yuichiro Okumura, MD, Hidetoshi Eguchi, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 12/2018
Einloggen, um Zugang zu erhalten
Excerpt
Currently, few effective treatment methods exist for patients with advanced or recurrent biliary tract cancer (BTC), mainly because most tumors are resistant to conventional chemotherapy and newer treatments.
1 Elucidation of the molecular mechanism of chemoresistance is likely to lead to novel therapeutic strategies for BTC. Hypoxia is an environmental stimulus that plays a pivotal role in the development and progression of several cancers. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2) is a potential target gene that can be induced via the hypoxia-inducible factor-1α (HIF-1α) pathway under hypoxia conditions.
2 This study focused on the roles of PLOD2 in BTC and investigated whether PLOD2 expression is associated with chemoresistance in BTC. …